Observational analysis reveals significant differences in GI adverse event profiles among NSAIDs, suggesting COX selectivity and dosage play crucial roles.
Conclusions: NSAIDs differ significantly in their GI adverse event profiles, influenced by COX selectivity and dosage. Both the likelihood and nature of potential GI harm should be considered when selecting an NSAID.
No takes yet. Share an insight, caveat, or question.
Kei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: